Transitioning from cerebrospinal fluid to blood tests to facilitate diagnosis and disease monitoring in Alzheimer's disease is a research paper published in Journal of Internal Medicine (2021). On theSindex it has a DataRank of 0. It has been cited 106 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Alzheimer's Drug Discovery Foundation
Grant: 201809‐2016862
Alzheimer's Drug Discovery Foundation
Grant: RDAPB‐201809‐2016615
Horizon 2020 Framework Programme
Grant: 860197
Multi-omics Interdisciplinary Research Integration to Address DEmentia diagnosis
EU Joint Programme – Neurodegenerative Disease Research
Grant: JPND2019‐466‐236
National Institutes of Health
Grant: 1R01AG068398‐01
European Research Council
Grant: 681712
Pathways to Alzheimer's disease
Hjärnfonden
Grant: FO2017‐0243
Hjärnfonden
Grant: FO2019‐0228
Medical Research Council
Grant: UKDRI-1001
Medical Research Council
Grant: MR/M003108/1
NIA NIH HHS
Grant: R01 AG068398
National Institutes of Health
Grant: 1R01AG068398-01
The effects of iron on oxidative stress and Alzheimer's biomarkers in amyloid-positive and negative elderly normal
National Institutes of Health
Grant: 5R01AG068398-02
The effects of iron on oxidative stress and Alzheimer's biomarkers in amyloid-positive and negative elderly normal
Alzheimer's Association
Stiftelsen för Gamla Tjänarinnor
UK Dementia Research Institute
Medical Research Council
Rosetrees Trust
Familjen Erling-Perssons Stiftelse
UCLH Biomedical Research Centre
National Institute for Health Research (NIHR)
FWCI
10.85
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals